Question:
To ask the Secretary of State for Health and Social Care, whether his Department plans to introduce a national screening programme for prostate cancer; and what steps his Department is taking to improve outcomes for people affected by the disease. (64497)
Tabled on: 02 July 2025
Answer:
Ashley Dalton:
The Department is guided on screening policy by the UK National Screening Committee (UK NSC). The UK NSC does not currently recommend a national screening programme for prostate cancer, as the current best test, the Prostate Specific Antigen test, lacks the necessary accuracy. It can lead to overdiagnosis and unnecessary treatment, as well as false reassurance for some men. This is particularly important given that many prostate cancers are slow-growing and may not cause harm during a man’s lifetime.
However, the UK NSC has commissioned a university to carry out a high-quality review and cost effectiveness model of the evidence for a national prostate cancer screening programme. This includes targeted approaches to high-risk groups and an offer to all men defined by age. The UK NSC expects to receive the report later this year.
In addition, the Government has invested £16 million in the £42 million United Kingdom-wide TRANSFORM trial, led by Prostate Cancer UK, which aims to identify new ways of detecting prostate cancer at an earlier stage, including in men without symptoms. The trial will ensure that at least 10% of participants are Black men, reflecting their higher risk and the importance of ensuring new tests are effective across all groups.
The National Cancer Plan will include details on how we will improve outcomes for cancer patients, including for those living with prostate cancer.
